Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SGSM2 antisense RNA 1 (SGSM2-AS1)
- Target
- SGSM2-AS1
- Molecular classification
- Long non-coding RNA, antisense RNA, non-protein-coding transcript
01
Overview
SGSM2 antisense RNA 1 (SGSM2-AS1) is a long non-coding RNA transcribed from the antisense strand of the SGSM2 locus. As an antisense lncRNA, it may play a role in the regulation of nearby gene expression via transcriptional interference, chromatin modification, or RNA-RNA interactions, but specific functions, disease associations, and therapeutic relevance have not been characterized. SGSM2-AS1 is not a well-established drug target, and little is known about its physiological or pathological roles[1][2][3].
- Other names
- SGSM2-AS1RP1-59D14.5
02
Mechanism of action
Not applicable; no drugs are known to act on SGSM2-AS1
03
Biological functions
Regulation of gene expression (in cis or trans)transcriptional interferencechromatin modulationpotentially alternative splicing and epigenetic control
04
Disease associations
No specific disease associations or roles have been reported for SGSM2-AS1 in the major literature; antisense lncRNAs as a class are frequently implicated in cancer, development, and immune regulation, but SGSM2-AS1 has not been specifically named in such contexts
05
Safety considerations
None described in the literature; general concerns for targeting lncRNAs relate to specificity, off-target effects, and poor understanding of functions
Beyond the preview
Go deeper on SGSM2 antisense RNA 1 (SGSM2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SGSM2 antisense RNA 1 (SGSM2-AS1).